Schonfeld Strategic Advisors »

Aeglea Biotherapeutics shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.4M 46k 29.41
2024-06-30 $1.8M 79k 23.51
2024-03-31 $1.3M 36k 37.93